Alpha-glucosidase inhibitor
Ohkura, T.; Taniguchi, S.-I.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 614-619
2012
ISSN/ISBN: 0047-1852 PMID: 22768587 Document Number: 661361
Document emailed within 1 workday
Related Documents
Osonoi, T. 2015: Alpha-glucosidase inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 390-394Katahira, H.; Ishida, H. 2002: Indication and side effect of alpha glucosidase inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 399-408
Pape, W.; Kochmann, R.; Kochmann, G.; Blank, M.; Baumann, K. 1983: Excretion of neutral alpha-glucosidase, determined with a continuous assay, and of acid alpha-glucosidase in the urine of human reference subjects Journal of Clinical Chemistry and Clinical Biochemistry 21(8): 511-517
Fehmann, H.C. 2000: Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol MMW Fortschritte der Medizin 142(21): 55
Fehmann, H.C. 2001: The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office Fortschritte der Medizin. Originalien 119 Suppl. 2: 55-61
Fehmann, H.C. 2000: Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office Fortschritte der Medizin. Originalien 118 Suppl. 2: 55-61
Fehmann, H.C. 2001: Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified MMW Fortschritte der Medizin 143(17): 46
Lee, S.M.; Bustamante, S.; Flores, C.; Bezerra, J.; Goda, T.; Koldovský, O. 1987: Chronic effects of an alpha-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice Journal of Pharmacology and Experimental Therapeutics 240(1): 132-137
Liu, Q.; Liu, S.-N.; Sun, S.-J.; Shen, Z.-F. 2013: Valibose, an alpha-glucosidase inhibitor, ameliorates the metabolic disorder of glucose and lipids and the nephropathy in streptozotocin-induced diabetic rats Yao Xue Xue Bao 48(8): 1227-1232
Gentile, S.; Turco, S.; Guarino, G.; Oliviero, B.; Rustici, A.; Torella, R. 1999: Non-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis: an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 14(1): 7-14
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1995: Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus Journal of International Medical Research 23(4): 279-283
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1995: Effect of alpha-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus Journal of International Medical Research 23(6): 492-496
Vannasaeng, S.; Ploybutr, S.; Nitiyanant, W.; Peerapatdit, T.; Vichayanrat, A. 1995: Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus Journal of the Medical Association of Thailand 78(11): 578-585
Okada, S.; Ishii, K.; Tanokuchi, S.; Hamada, H.; Ichiki, K.; Ota, Z. 1996: Use of an alpha-glucosidase inhibitor to synchronize sugar absorption with delayed insulin secretion in a patient with non-insulin-dependent diabetes mellitus Journal of International Medical Research 24(1): 164-168
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679
Suzuki, I.; Kushida, H.; Shida, H. 1970: Mammalian glycosidases. IV. Characterization of alpha-D-mannosidase, alpha-D-glucosidase and beta-D-galactosidase and other various glycosidase activities in organs of rabbits and cats Seikagaku. Journal of Japanese Biochemical Society 42(7): 361-371
Fukuda, C.; Iijima, K.; Inoue, N.; Takashima, Y.; Urabe, C.; Nakamura, K. 1988: Clinical evaluation of alpha 2 plasmin inhibitor and alpha 2 plasmin inhibitor-plasmin complex by enzyme immunoassay method--with special reference to accident surgery Rinsho Byori. Japanese Journal of Clinical Pathology 36(3): 346-350
Kalra, S. 2014: Alpha glucosidase inhibitors Jpma. Journal of the Pakistan Medical Association 64(4): 474-476
Laube, H.; Fouladfar, M.; Aubell, R.; Schmitz, H. 1980: Effect of glucosidase inhibitor, Bay g 5421 (acarbose), on the blood glucose in obese diabetic patients ty pe 2 (NIDDM) Arzneimittel-Forschung 30(7): 1154-1157
Kamiya, T.; Takamatsu, J.; Koie, K.; Kohakura, M. 1981: Metabolism of alpha 2-plasmin inhibitor ( alpha 2-PI) in a patient with congenital alpha 2-Pi deficiency Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(7): 1513-1519